LianBio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020
Cash & Equivalents	79.22	228.18	254.35
Short-Term Investments	223.14	155.07	0
Cash & Cash Equivalents	302.36	383.25	254.35
Cash Growth	-21.11%	50.68%	-
Receivables	1.77	6.04	20
Other Current Assets	8.64	10.35	2.4
Total Current Assets	312.77	399.65	276.75
Property, Plant & Equipment	7.09	6.65	2.53
Long-Term Investments	0.07	20	0
Other Long-Term Assets	0.02	0.05	0.01
Total Long-Term Assets	7.19	26.7	2.54
Total Assets	319.96	426.34	279.29
Accounts Payable	1.45	3.23	4.33
Current Debt	1.85	1.13	0.54
Other Current Liabilities	20.31	10.74	1.36
Total Current Liabilities	23.62	15.09	6.23
Long-Term Debt	2.49	3.71	1.34
Other Long-Term Liabilities	0.21	20.21	20
Total Long-Term Liabilities	2.7	23.92	21.34
Total Liabilities	26.31	39.01	27.57
Total Debt	4.34	4.83	1.88
Debt Growth	-10.24%	157.13%	-
Retained Earnings	-470.53	-360.24	-163.94
Comprehensive Income	-2.08	0.53	-0.04
Shareholders' Equity	259.87	353.56	-132.84
Net Cash / Debt	298.02	378.42	252.47
Net Cash / Debt Growth	-21.24%	49.89%	-
Net Cash Per Share	2.76	11.00	20.95
Working Capital	289.16	384.56	270.52
Book Value Per Share	2.41	10.28	-11.02

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).